ABC transporters, drug resistance, and cancer stem cells.
about
Salinomycin as a drug for targeting human cancer stem cellsBypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and RadiotherapyTherapeutic strategies targeting cancer stem cellsCaveolin-1, a stress-related oncotarget, in drug resistanceSide population cells as prototype of chemoresistant, tumor-initiating cellsIn vivo molecular imaging of cancer stem cellsUnderstanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease ProgressionEmerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachCan nanomedicines kill cancer stem cells?A new prospect in cancer therapy: targeting cancer stem cells to eradicate cancerDoxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse modelsBreast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonistMolecular evolutionary analysis of ABCB5: the ancestral gene is a full transporter with potentially deleterious single nucleotide polymorphismsGlycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cellsIMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine modelPinellia pedatisecta agglutinin targets drug resistant K562/ADR leukemia cells through binding with sarcolemmal membrane associated protein and enhancing macrophage phagocytosisTRAIL-mediated apoptosis in breast cancer cells cultured as 3D spheroidsA comparative genomic analysis of putative pathogenicity genes in the host-specific sibling species Colletotrichum graminicola and Colletotrichum sublineolaMultidrug-resistance proteins are weak tumor associated antigens for colorectal carcinoma.Cancer stem cells and their mechanism of chemo-radiation resistancePre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers.Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cells.Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions.Gene expression profiling of human breast tissue samples using SAGE-SeqABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets.Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2.In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cellsGLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent stateEstrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein.The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis.β-catenin knockdown enhances the effects of fluorouracil in the breast cancer cell line MDA-MB-468.Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristicsSide population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.CM2 antigen, a potential novel molecule participating in glucuronide transport on rat hepatocyte canalicular membrane.Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.Prognostic role of CD133 expression in colorectal cancer: a meta-analysisCD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
P2860
Q21285139-7CCE02A7-ED6E-48D6-A815-25401CA08CFDQ26772300-17DA9549-657A-428E-84A9-1E47F8A48C44Q26781398-C9851D7A-AF1C-4C75-9E9F-ED4A14CB1BECQ26782615-338D14DB-76C5-472E-BE34-EDD8607B4806Q26823433-0915546D-F1AC-44B5-923B-8E4D5B0FFF7DQ26828630-2B60C073-7EAB-47C2-9207-87634E36B921Q26829949-BBA8BD8D-B322-47BE-847E-A37F6DDDBCA3Q26849477-D4AEEA79-C94A-440F-BDC9-BE76332F08F3Q27022017-69BF23F5-ED3E-4B8C-BA0D-65CA6937B20CQ27022134-C2C35823-DDAD-498F-B60D-2927B9753C1EQ28473783-211909FA-F4E9-43CD-B87B-FB59B7E83D64Q28475994-09F4FD8A-FAD4-433C-8630-3989FE573719Q28476833-2E325DCC-3456-439D-8DC4-F677F96669D6Q28477764-56BAF4ED-7643-4DF6-B32D-665ECFDEC922Q28535709-95F597E1-BA8C-4311-9CA4-B79CCEABF4E1Q28536615-FCBC1EA0-9485-49FB-9449-2231FF7C69F4Q28544399-3926FE38-5C37-479D-85DA-6116850A6AF2Q28564092-BC2BDC9E-7866-4662-AB46-1B5447B25C63Q31022597-8CB09078-4546-4C48-B7B4-C951471160ACQ33614696-77763C3B-9AF7-42BB-900F-E9D9C61FA950Q33626025-7EAD697E-3402-431B-B97C-F44AF06EF726Q33690881-205731EE-E2C8-45D6-88FA-4C3388E51900Q33732120-D7EA9EF0-AFFD-4E13-B6C0-84FCE8251544Q33736475-1226B0E5-417B-4DE3-A993-D68AEAD85CCEQ33739392-689AFAC3-2064-4AF5-86B7-F00FD412162FQ33753279-FFF9E6C7-D0D1-4083-8491-AF978652E267Q33796082-5E108B3F-9D2C-4C33-9504-EA9868A45489Q33816271-A70F581C-E426-482B-B350-C51EF82F907CQ33895232-38DE7E06-31C1-411B-B62F-3F5FFAA5BE0BQ33919758-6EE4A68B-B0B0-49FF-A1DC-06BE865F0337Q34035224-4A69D010-A0AA-4234-AF2E-85FBC647200AQ34105402-22241EC6-80D0-475D-9995-EC2896E518D0Q34218232-F6D16EEE-2266-444B-A82A-891D1FC1206EQ34265458-086C184E-F1B4-4B14-A967-102E3EDF41BBQ34267466-0184020E-4677-4BD0-9934-B87260697F10Q34279342-B213A98F-75BA-49F8-B171-E87136E01883Q34426099-5594FB03-D979-4C54-9C9E-7B3A5D962E7AQ34469657-9CFE15CF-A19A-493F-B5C9-B7F10A675873Q34502600-7DCA8AD5-E180-452C-A6B4-C4A92AC5E4EFQ34533871-88C722F4-7B3F-47C4-A278-339945FB3451
P2860
ABC transporters, drug resistance, and cancer stem cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on 18 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
ABC transporters, drug resistance, and cancer stem cells.
@en
ABC transporters, drug resistance, and cancer stem cells.
@nl
type
label
ABC transporters, drug resistance, and cancer stem cells.
@en
ABC transporters, drug resistance, and cancer stem cells.
@nl
prefLabel
ABC transporters, drug resistance, and cancer stem cells.
@en
ABC transporters, drug resistance, and cancer stem cells.
@nl
P1476
ABC transporters, drug resistance, and cancer stem cells.
@en
P2860
P2888
P356
10.1007/S10911-009-9109-9
P50
P577
2009-02-18T00:00:00Z